GPC3 and hepatocellular carcinoma: To develop CAR‐T therapy for solid tumors, antigens that are specifically expressed on the surface of cancer cells need to be explored, and GPC3 may serve as a promising antigen for generating CAR‐T cells targeting HCC.289